Published in Int J Oncol on May 01, 1994
Molecular cloning and expression of a human B-cell growth factor gene in Escherichia coli. Science (1987) 2.65
A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. EMBO J (1992) 2.19
Biochemical separation of a human B cell mitogenic factor. Proc Natl Acad Sci U S A (1982) 1.68
Presence of a highly repetitive and widely dispersed DNA sequence in the human genome. Proc Natl Acad Sci U S A (1981) 1.67
The influence of the surgical wound on local tumor recurrence. Surgery (1989) 1.65
The high-velocity pulmonary injury. Relation to traumatic wet lung syndrome. J Thorac Cardiovasc Surg (1972) 1.52
Becker's melanosis: associated abnormalities. J Am Acad Dermatol (1983) 1.33
Identification of a signal sequence necessary for the unconventional secretion of Engrailed homeoprotein. Curr Biol (1998) 1.22
Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients. J Clin Invest (1977) 1.19
Pseudo-obstruction of the colon. Surg Gynecol Obstet (1971) 1.01
Rhinophycomycosis entomophthorae. Arch Dermatol (1978) 0.98
Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck. Am J Surg (1974) 0.94
Proliferation of human B lymphocytes mediated by a soluble factor. Fed Proc (1983) 0.91
Systematized porokeratotic eccrine and hair follicle naevus: report of a case and review of the literature. Br J Dermatol (1999) 0.89
Vitamin D-mediated gene regulation in phenotypically defined human B cell subpopulations. Endocrinology (2000) 0.89
Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line. Cancer Chemother Pharmacol (2000) 0.89
Paclitaxel and concurrent radiation for gastric cancer. Int J Radiat Oncol Biol Phys (2000) 0.87
Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide. Leuk Res (1999) 0.87
Effect of cell trypsinization on nuclear proteins of WI-38 fibroblasts in culture. J Cell Physiol (1975) 0.87
Novel diversity in IL-4-mediated responses in resting human naive B cells versus germinal center/memory B cells. J Immunol (2000) 0.85
A Southeastern Cancer Study Group phase I/II trial with vaccinia melanoma oncolysates. Cancer (1986) 0.85
Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells. J Immunol (1991) 0.85
Chemoradiotherapy for advanced inoperable head and neck cancer: A phase II study. Semin Radiat Oncol (1999) 0.85
Treatment of bullous mastocytosis with disodium cromoglycate. J Am Acad Dermatol (1983) 0.84
A phase I/II SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO). Am Surg (1986) 0.84
Participation of the melanocortin-1 receptor in the UV control of pigmentation. J Investig Dermatol Symp Proc (1999) 0.84
Positive relationship of clinical and serologic responses to vaccinia melanoma oncolysate. Arch Surg (1987) 0.84
Growth factor-mediated tumor cell proliferation in hairy cell leukemia. J Exp Med (1985) 0.83
Characterization of B cell growth in systemic lupus erythematosus. Effects of recombinant 12-kDa B cell growth factor, interleukin 4 and transforming growth factor-beta. Eur J Immunol (1990) 0.83
Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccine. Cancer Immunol Immunother (1995) 0.83
A Fas-associated death domain protein-dependent mechanism mediates the apoptotic action of non-steroidal anti-inflammatory drugs in the human leukemic Jurkat cell line. J Biol Chem (2001) 0.83
Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer. Cancer Invest (2001) 0.83
1alpha,25-Dihydroxyvitamin D3 modulates CD38 expression on human lymphocytes. J Immunol (1996) 0.82
Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer. Am J Surg (1993) 0.82
Lymphocyte transformation in vitro to RII mouse milk antigen among woman with breast disease. Cell Immunol (1976) 0.82
Evolutionary divergence of LFY function in the mustards Arabidopsis thaliana and Leavenworthia crassa. Plant Mol Biol (2006) 0.82
Paclitaxel and concurrent radiation for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys (2001) 0.82
Generation of cytotoxic antibodies to the B16 murine melanoma using a formalinized vaccine. Int J Cancer (1993) 0.82
Requirements for induction of vitamin D-mediated gene regulation in normal human B lymphocytes. J Immunol (1996) 0.82
Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer. Int J Radiat Oncol Biol Phys (1994) 0.81
Dose local x-irradiation of a tumor increase the incidence of metastases? Cancer (1981) 0.80
Macrophage migration inhibitory factor (MIF)--its role in catecholamine metabolism. Cell Mol Biol (Noisy-le-grand) (1999) 0.80
Modulation of IL-2-induced human B cell proliferation in the presence of human 50-kDa B cell growth factor and IL-4. J Immunol (1989) 0.80
Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction. Semin Radiat Oncol (1999) 0.79
Regulation of interleukin-13 receptor constituents on mature human B lymphocytes. J Biol Chem (1998) 0.79
A new mouse model of experimental melanoma for vaccine and lymphokine therapy. Int J Oncol (1998) 0.79
Phase II study of 5-fluoruracil leucovorin and azidothymidine in patients with metastatic colorectal cancer. J Cancer Res Clin Oncol (1996) 0.79
Establishment of stable human T-T hybridomas. J Immunol Methods (1985) 0.79
Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck cancers: a phase II study--preliminary results. Semin Oncol (1997) 0.78
Moist wound healing under a vapor permeable membrane. J Am Acad Dermatol (1983) 0.78
Loss of intracisternal A-type retroviral particles in BL6 melanoma cells transfected with MHC class I genes. J Gen Virol (1996) 0.78
The human B cell response to IL-13 is dependent on cellular phenotype as well as mode of activation. J Immunol (1999) 0.77
Basic fibroblast growth factor production and growth factor receptors as potential targets for melanoma therapy. Melanoma Res (1992) 0.77
Extramedullary plasmacytoma of upper respiratory tract. Recurrence after latency of thirty-six years. N Y State J Med (1966) 0.77
The effect of decreased muscle energy stores on the VO2 kinetics at the onset of exercise. Eur J Appl Physiol Occup Physiol (1989) 0.77
Differential regulation of vitamin D receptors in clonal populations of a chronic myelogenous leukemia cell line. Exp Cell Res (1996) 0.76
Defective suppressor cell activity in cancer patients: a defect in immune regulation. Cancer (1981) 0.76
Nude mouse model to study passive humoral immunotherapy directed against B16 F10 murine melanoma. J Surg Oncol (1994) 0.76
Taxol pretreatment of tumor targets amplifies natural killer cell mediated lysis. Leuk Lymphoma (1997) 0.76
Delayed cutaneous hypersensitivity reactions and prognosis in patients with cancer. Ann N Y Acad Sci (1976) 0.75
Evidence for an intracellular precursor for human B-cell growth factor. Proc Natl Acad Sci U S A (1984) 0.75
Tuberculous tenosynovitis in a patient with hyperuricemia. Calif Med (1966) 0.75
Negative modulation of Epstein-Barr virus episomes by a human B-cell growth factor. J Virol (1989) 0.75
Response: complementary DNA for 12-kilodalton B cell growth factor: misassigned. Science (1996) 0.75
The surgical management of "in situ" melanoma. J Dermatol Surg Oncol (1982) 0.75
Immunology for advanced breast cancer. Compr Ther (1978) 0.75
B700 antigen as a component of an antimelanoma vaccine: formalinized extracellular antigens. Pigment Cell Res (1992) 0.75
Preimmunization of mice with formalinized extracellular antigens of melanoma in combination with IL-2 and surgical resection increased survival and tumor control in metastatic melanoma model. J Surg Oncol (1993) 0.75
Structural alterations of chromatin in phase III W138 human diploid fibroblasts. Exp Cell Res (1975) 0.75
High-velocity pulmonary injury. Relation to traumatic wet-lung syndrome. N Y State J Med (1972) 0.75
Lymphokine-activated effector cells: modulation of activity by cytokines. Lymphokine Cytokine Res (1992) 0.75
The influence of warfarin of levamisole on the incidence of metastases following local irradiation of a solid tumor. Cancer (1982) 0.75
Osseous metastasis: its relationship to primary carcinoma of the head and neck. Am J Surg (1974) 0.75
Response. Science (1994) 0.75
Intrasplenic vaccination against experimental melanoma. Int J Oncol (1996) 0.75
Immunization of mice with melanoma cells transfected to secrete the superantigen, staphylococcal enterotoxin A. Cancer Immunol Immunother (1998) 0.75
Role of biologic therapy in surgical management of hepatic metastases. J Surg Oncol (2010) 0.75
Induction of interleukin-2, natural killer cell activity and anti-melanoma antibodies resulting from immunization of mice with formalinized extracellular antigens (FECA) of murine melanoma. Melanoma Res (1992) 0.75
What you can do about colorectal cancer. Va Med (1984) 0.75